Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (TCBIO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (TCBIO:NASDAQ), powered by AI.

Current Price
$20.63
Sector
Financial Services
What is the Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B stock price forecast?

Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B is currently trading at $20.63. View real-time AI analysis on Alpha Lenz.

What is Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B insider trading activity?

View the latest insider trading data for Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B on Alpha Lenz.

What is Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B's P/E ratio?

View Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B's valuation metrics on Alpha Lenz.

Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B

NASDAQ · TCBIO
$20.63-0.07(-0.34%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B's future dividend policy...
Alpha Chat Insight

Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B's ROE is 9.4%. Explore profitability and growth together.

Ask for details

Company Overview

Texas Capital Bancshares, 5.75% Perpetual Preferred Stock Series B is a hybrid financial instrument issued by Texas Capital Bancshares, a prominent financial services holding company. As a preferred stock, it offers investors a fixed dividend yield of 5.75%, providing a steady income stream that takes precedence over common stock dividends but follows bond interest payments in the priority hierarchy. The perpetual nature of this preferred stock means it has no maturity date, allowing the company to have a permanent capital without a redemption requirement at a future date. This asset primarily caters to income-focused investors seeking stable returns within the banking and financial services sector. It plays a significant role in the issuer's capital structure, providing financial flexibility and strengthening its equity base. By offering such an asset, Texas Capital Bancshares can effectively manage its capital requirements while supporting its growth and operational strategies in competitive financial markets.

CEOMr. Robert C. Holmes
SectorFinancial Services
IndustryBanks - Regional
Employees1,818

Company Statistics

FY 2025

Profile

N/AMarket Cap
$1.26BRevenue
0.00Shares Out
1,818Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
34.46%Pre-Tax
26.30%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

8.74%Rev 3Yr
4.88%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-0.22%Net Inc 3Yr
37.87%Net Inc 5Yr

Returns

1.06%ROA
9.44%ROE
N/AROIC

Financial Health

$2.10BCash & Cash Equivalents
$25.81BNet Debt
768.55%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (ticker: TCBIO) is a company listed on NASDAQ in the Financial Services sector (Banks - Regional). It has approximately 1,818 employees.

The current price is $20.63 with a P/E ratio of -x and P/B of -x.

ROE is 9.44%. Annual revenue is $1.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Texas Capital Bancshares, Inc. 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (TCBIO) Stock Forecast 2026 $20.63 — Price, Financials & Analyst Targets | Alpha Lenz